(CCM) Concord Medical Holdings - Ratings and Ratios
Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US2062771058
CCM: Cancer, Radiotherapy, Imaging, Equipment, Hospitals, Diagnostics, Research
Concord Medical Services Holdings Limited (NYSE:CCM) is a leading healthcare provider in China, specializing in radiotherapy and diagnostic imaging services. Established in 1997 and headquartered in Beijing, the company operates through two primary segments: Network and Hospital. Its network includes advanced cancer treatment centers equipped with cutting-edge technologies such as linear accelerators, proton therapy systems, and gamma knife radiosurgery. Additionally, the company offers diagnostic imaging services, including positron emission tomography-computed tomography (PET-CT) and magnetic resonance imaging (MRI) scanners.
Concord Medical extends beyond clinical services, providing comprehensive support to healthcare professionals. This includes developing treatment protocols, organizing joint diagnoses, and assisting in the recruitment and compensation of medical personnel. The company also leases radiotherapy and diagnostic equipment to hospitals and offers premium cancer and proton treatment services. Its teleconsultation and medical information technology services further enhance accessibility and efficiency in patient care. Moreover, Concord Medical operates specialty cancer hospitals, delivering a range of services including radiation therapy, imaging, laboratory testing, and inpatient care.
As a key player in Chinas healthcare sector, Concord Medical Services Holdings Limited is well-positioned to address the growing demand for advanced oncology treatments and diagnostic solutions. Its integrated approach combines state-of-the-art technology, clinical expertise, and operational support, making it a critical partner for hospitals and healthcare providers in China.
3-Month Forecast: Based on the provided
Additional Sources for CCM Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCM Stock Overview
| Market Cap in USD | 23m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2009-12-11 |
CCM Stock Ratings
| Growth 5y | -76.4% |
| Fundamental | -52.5% |
| Dividend | 1.31% |
| Rel. Strength Industry | 10 |
| Analysts | - |
| Fair Price Momentum | 3.44 USD |
| Fair Price DCF | - |
CCM Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 4.4% |
CCM Growth Ratios
| Growth Correlation 3m | -3.9% |
| Growth Correlation 12m | -44.3% |
| Growth Correlation 5y | -83.7% |
| CAGR 5y | -23.87% |
| CAGR/Max DD 5y | -0.26 |
| Sharpe Ratio 12m | -0.22 |
| Alpha | 11.97 |
| Beta | -0.80 |
| Volatility | 96.72% |
| Current Volume | 8.6k |
| Average Volume 20d | 1.2k |
As of March 15, 2025, the stock is trading at USD 4.44 with a total of 8,590 shares traded.
Over the past week, the price has changed by +3.02%, over one month by -6.92%, over three months by -9.20% and over the past year by +11.00%.
No, based on ValueRay Fundamental Analyses, Concord Medical Holdings (NYSE:CCM) is currently (March 2025) a stock to sell. It has a ValueRay Fundamental Rating of -52.54 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCM as of March 2025 is 3.44. This means that CCM is currently overvalued and has a potential downside of -22.52%.
Concord Medical Holdings has no consensus analysts rating.
According to ValueRays Forecast Model, CCM Concord Medical Holdings will be worth about 3.7 in March 2026. The stock is currently trading at 4.44. This means that the stock has a potential downside of -16.44%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 1.2 | -73% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 3.7 | -16.4% |